← Evidence map

ArticleOncotarget2017

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models.

Shu-Fu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28476040